Astellas has won a reprieve in its attempt to stop Pfizer's generic medicines unit Hospira ... making it one of Astellas top products. It was first launched in the US in 2008.

Sun Pharma Advanced Research Company Ltd. key Products/Revenue Segments include Sale of services for the year ending 31-Mar-2024.For the quarter ended 31-12-2024, the company has reported a ...

Strides Pharma Science Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue and Sale of services for the year ending 31-Mar-2024.For the quarter ended 31-12-2024, the ...